Abstract:Background/Methods: For mechanistic studies, in-vitro human B-cell differentiation and generation of plasma cells are invaluable techniques. However, the heterogeneity of both T-cell-dependent (TD) and T-cell-independent (TI) stimuli and the disparity of culture conditions used in existing protocols make the interpretation of results challenging. The aim of the present study was to achieve the most optimal B-cell differentiation conditions using isolated CD19 + B cells and peripheral blood mononuclear cell (PBMC) cultures. We addressed multiple seeding densities, different durations of culturing, and various combinations of TD and TI stimuli including B-cell receptor (BCR) triggering. B-cell expansion, proliferation, and differentiation were analyzed after 6 and 9 days by measuring B-cell proliferation and expansion, plasmablast and plasma cell formation, and immunoglobulin (Ig) secretion. In addition, these conditions were extrapolated using cryopreserved cells and differentiation potential was compared. Results: This study demonstrates improved differentiation efficiency after 9 days of culturing for both B-cells and PBMC cultures using CD40L and IL-21 as TD stimuli and 6 days for CpG and IL-2 as TI stimuli. We arrived at optimized protocols requiring 2,500 and 25,000 B–cells per culture well for the TD and TI assays, respectively. The results of the PBMC cultures were highly comparable to the B-cell cultures, which allows dismissal of additional B-cell isolation steps prior to culturing. In these optimized TD conditions, the addition of anti-BCR showed a little effect on phenotypic B-cell differentiation; however, it interferes with Ig secretion measurements. The addition of IL-4 to the TD stimuli showed significantly lower Ig secretion. The addition of BAFF to optimized TI conditions showed enhanced B-cell differentiation and Ig secretion in B-cell but not in PBMC cultures. With this approach, efficient B-cell differentiation and Ig secretion were accomplished when starting from fresh or cryopreserved samples. Conclusion: Our methodology demonstrates optimized TD and TI stimulation protocols for more in-depth analysis of B-cell differentiation in primary human B-cell and PBMC cultures while requiring low amounts of B cells, making them ideally suited for future clinical and research studies on B-cell differentiation of patient samples from different cohorts of B-cell-mediated diseases.

The Optimization of the Methods and the Influencing Factors of Establish Human B Lymphoblastoid Cell Lines

A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines

[Model of B Immunoblastic Lymphomas in the Hu-PBL-SCID Mice].

[Establishment of Long-Term Culture System for Human B Cells Derived from Peripheral Blood Mononuclear Cells Activated Via Soluble CD40 Ligand].

The Construction of Human B Lymphocyte Stimulator-Transfected Cells and Effects of Its Signal on B Lymphocytes

Establishment of Epstein-Barr virus-transformed B cell lines from healthy volunteers of type B

Enhanced Outgrowth of EBV-transformed Chronic Lymphocytic Leukemia B Cells Mediated by Coculture with Macrophage Feeder Cells.

Manipulation of human B cells to confer immortality

Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells

Reprogramming of EBV-immortalized B-lymphocyte Cell Lines into Induced Pluripotent Stem Cells

The Effects of CD40L on the Phenotypes and IL-12 Secretion of B Lymphocytes

Study on quality control of immortal lymphoblastoid cell lines derived from ethnic groups

Establishment and Evaluation of a Bi-Phase Culture System for the Culture of Primary B-lineage Precursor Leukemic Blasts in Vitro

The Long Term Cultured Of Human B Cells From Pbmcs Stimulated Via Soluble Cd40l For The Enhancement Of Antigen Presentation In Vitro

LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders

Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth

Establishment of immortalized lymphoblastoid cell bank of vascular dementia

Study of Biologic Characteristics on Epstein-Barr Virus Transformed B Lymphocytes Carrying Hepatitis C Virus Type Ⅱ

In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone

Progress in Bcell immortalization methods

Properties and heterogeneity of human fetal pre-B cells transformed by EBV